Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2022-04-08 15:35:25
Reference is made to the announcement made by Nykode Therapeutics AS on March
31, 2022, regarding exercise of warrants by a board member. The share capital
increase has now been registered with the Norwegian Register of Business
Enterprises, and the company's new share capital is NOK 2,900,694.09, divided
into 290,069,409 shares, each with a par value of NOK 0.01.